Two Companies Join Hands To Develop Point-Of-Care Covid-19 Test Using CRISPR Technology
Cambridge, Massachusetts-based Sherlock Biosciences has partnered with binx health, based in Boston, to develop a point-of-care test for Covid-19 using CRISPR technology. Sherlock received an emergency use authorization for its…
Share